Search research articles
Contact Us
Filters
Showing results (241-250 of 252) with videos related to
Page
of 26
Sort By:
NPJ Precision Oncology
|
January 23, 2026
Identification and characterization of MARCO-expressing tumor-associated macrophages in pancreatic ductal adenocarcinoma with pan-cancer relevance
Hao Sun, Mengya Gao, Zexing Liu, et al.
Cell Reports. Medicine
|
March 18, 2026
FBXO3-mediated DUSP9 ubiquitination promotes leukemia stem cell maintenance and tyrosine kinase inhibitor resistance in chronic myeloid leukemia
Xudong Li, Shiyu Zuo, Yanli Zhang, et al.
Blood
|
January 10, 2023
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial
Yuqin Song, Hervé Tilly, Shinya Rai, et al.
Blood Science (Baltimore, Md.)
|
September 3, 2025
China Expert consensus on the application of metagenomic next-generation sequencing for the etiological diagnosis of infections in hematological disorders (2024)
Chunhui Xu, Ren Lin, Ye Bai, et al.
Biomarker Research
|
June 27, 2026
CD163<sup>+</sup> macrophages coordinate erythroblastic Island formation and iron metabolism to enable glucocorticoid-induced erythropoiesis
Mengjia Li, Yaomei Wang, Hong Huang, et al.
Journal of Hematology & Oncology
|
April 18, 2020
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma
Yuankai Shi, Yongping Song, Yan Qin, et al.
Cancer Biology & Medicine
|
March 2, 2023
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Ping Li, Yang Liu, Yun Liang, et al.
Frontiers in Oncology
|
November 22, 2021
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China
Weiping Liu, Donglu Zhao, Ting Liu, et al.
Innovation (Cambridge (Mass.))
|
May 14, 2023
Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III study
Huijuan Zhong, Shu Cheng, Xi Zhang, et al.
Haematologica
|
April 10, 2025
Dynamic change in Epstein-Barr virus DNA predicts prognosis in early stage natural killer/T-cell lymphoma with pegaspargase-based treatment: long-term follow-up and biomarker analysis from the NHL-004 multicenter randomized study
Huijuan Zhong, Shu Cheng, Jie Xiong, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 252) with videos related to
Sort By:
Page
of 26
NPJ Precision Oncology
|
January 23, 2026
Identification and characterization of MARCO-expressing tumor-associated macrophages in pancreatic ductal adenocarcinoma with pan-cancer relevance
Hao Sun, Mengya Gao, Zexing Liu, et al.
Cell Reports. Medicine
|
March 18, 2026
FBXO3-mediated DUSP9 ubiquitination promotes leukemia stem cell maintenance and tyrosine kinase inhibitor resistance in chronic myeloid leukemia
Xudong Li, Shiyu Zuo, Yanli Zhang, et al.
Blood
|
January 10, 2023
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial
Yuqin Song, Hervé Tilly, Shinya Rai, et al.
Blood Science (Baltimore, Md.)
|
September 3, 2025
China Expert consensus on the application of metagenomic next-generation sequencing for the etiological diagnosis of infections in hematological disorders (2024)
Chunhui Xu, Ren Lin, Ye Bai, et al.
Biomarker Research
|
June 27, 2026
CD163<sup>+</sup> macrophages coordinate erythroblastic Island formation and iron metabolism to enable glucocorticoid-induced erythropoiesis
Mengjia Li, Yaomei Wang, Hong Huang, et al.
Journal of Hematology & Oncology
|
April 18, 2020
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma
Yuankai Shi, Yongping Song, Yan Qin, et al.
Cancer Biology & Medicine
|
March 2, 2023
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Ping Li, Yang Liu, Yun Liang, et al.
Frontiers in Oncology
|
November 22, 2021
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China
Weiping Liu, Donglu Zhao, Ting Liu, et al.
Innovation (Cambridge (Mass.))
|
May 14, 2023
Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III study
Huijuan Zhong, Shu Cheng, Xi Zhang, et al.
Haematologica
|
April 10, 2025
Dynamic change in Epstein-Barr virus DNA predicts prognosis in early stage natural killer/T-cell lymphoma with pegaspargase-based treatment: long-term follow-up and biomarker analysis from the NHL-004 multicenter randomized study
Huijuan Zhong, Shu Cheng, Jie Xiong, et al.
Page
of 26